Hepatocellular carcinoma recurrence: Predictors and management.

Area of Science:

• Hepatology
• Oncology
• Cancer Research

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally, with over 830,000 deaths annually.
• Despite curative treatments like surgical resection and ablative therapies, HCC recurrence rates exceed 50%, with 70% of patients experiencing recurrence within five years post-surgery.

Purpose of the Study:

• To review predictors of HCC recurrence following various treatment modalities.
• To discuss patient stratification approaches for recurrent HCC.
• To highlight the need for improved guidelines and surveillance protocols for HCC recurrence.

Main Methods:

• Literature review of studies on HCC recurrence.
• Analysis of predictors for recurrence after different treatments.
• Evaluation of current patient stratification strategies.

Main Results:

• High rates of HCC recurrence are observed across multiple treatment modalities.
• Predictors for recurrence vary depending on the initial treatment received.
• Existing guidelines for managing recurrent HCC are insufficient.

Conclusions:

• Effective management of recurrent HCC requires further research and defined strategies.
• Development of specific guidelines and strict surveillance protocols is crucial for improving patient outcomes after initial HCC treatment.